Showing results (61-70 of 197) with videos related to

Sort By:
Pageof 20
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 27, 2012
Lipoprotein(a) plasma levels and the risk of cancer: the PRIME studyÉmilie Marrer, Aline Wagner, Michèle Montaye, et al.
Journal of Clinical Lipidology|December 7, 2016
Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based studyJean Ferrières, Jean Dallongeville, Michel Rossignol, et al.
Annals of Epidemiology|March 1, 2022
Trends of in-hospital and out-of-hospital coronary heart disease mortality in French registries during the period 2000 to 2016Stefy Gbokou, Katia Biasch, Jean Dallongeville, et al.
The American Journal of Cardiology|January 27, 2009
Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort)Virginie Gardette, Vanina Bongard, Jean Dallongeville, et al.
Stroke|August 9, 2019
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial FibrillationPatrick Blin, Laurent Fauchier, Caroline Dureau-Pournin, et al.
BMC Medical Genetics|September 16, 2008
The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglyceridesJean Dallongeville, Dominique Cottel, Aline Wagner, et al.
European Journal of Epidemiology|December 29, 2010
Ten-year risk of all-cause mortality: assessment of a risk prediction algorithm in a French general populationEmilie Bérard, Vanina Bongard, Dominique Arveiler, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 23, 2019
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort studyLaurent Fauchier, Patrick Blin, Frédéric Sacher, et al.
Preventive Medicine|September 13, 2015
Expired-air carbon monoxide as a predictor of 16-year risk of all-cause, cardiovascular and cancer mortalityEmilie Bérard, Vanina Bongard, Jean Dallongeville, et al.
Plos One|December 7, 2021
Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI)Vincent Cottin, Lionel Bensimon, Fanny Raguideau, et al.
Pageof 20